December 25th 2024
Monjuvi plus Revlimid and Rituxan demonstrated improved progression-free survival for patients with relapsed or refractory follicular lymphoma.
December 24th 2024
December 23rd 2024
December 20th 2024
December 18th 2024
December 22nd 2024
December 18th 2024
December 16th 2024
December 15th 2024
November 30th 2024
November 27th 2024
November 23rd 2024
November 16th 2024